Department of Neurology, Thomayer University Hospital, Prague, Czech Republic.
Third Faculty of Medicine, Charles University, Prague, Czech Republic.
Behav Neurol. 2022 Sep 8;2022:6075511. doi: 10.1155/2022/6075511. eCollection 2022.
Primary progressive aphasia (PPA) is a clinically variable syndrome manifesting as slow progressive loss of speech and language with multiple underlying neurodegenerative pathologies.
We included data from nine PPA patients with available autopsies. We then retrospectively reviewed all available medical records, neuropsychology, and MRI results to confirm the corresponding subtypes of PPA and compared them with postmortem neuropathological results.
Clinical presentations corresponded to the nonfluent/agrammatic variant in six cases, the semantic variant in one case, the logopenic variant in one case, and the mixed variant (concomitant nonfluent/agrammatic plus semantic variant) in one case. Patients with a broader clinical presentation, i.e., combining manifestations of one PPA subtype and symptoms of another PPA variant, had autopsy comorbidities showing multiple neurodegenerative disorders. Of the nine subjects enrolled in the study, Alzheimer's disease (AD) was found in eight cases; however, in only one case, AD was detected as an isolated neuropathological substrate of PPA. In eight brain samples, different comorbid neuropathologies were detected: three cases with comorbid AD and dementia with Lewy bodies, two cases with comorbid AD and TDP-43 pathology, one case with comorbid AD and complex tauopathies, and one case with comorbid AD with both tau and TDP-43 deposits. Finally, one case had comorbid tau and TDP-43 pathology but without comorbid AD pathology.
Our observation suggests that PPA cases could be more heterogeneous in their etiology than previously thought and underlying neurodegenerative comorbidities should be considered in routine practice, especially if the clinical presentation of PPA is atypical.
原发性进行性失语症(PPA)是一种临床表现多样的综合征,以言语和语言缓慢进行性丧失为特征,其潜在的神经退行性病变有多种。
我们纳入了 9 例有尸检结果的 PPA 患者的数据。然后回顾性分析了所有可用的病历、神经心理学和 MRI 结果,以确认相应的 PPA 亚型,并将其与死后神经病理学结果进行比较。
6 例临床表现符合非流利/语法障碍型,1 例符合语义型,1 例符合完全性失语型,1 例符合混合型(同时存在非流利/语法障碍型和语义型)。临床表现更广泛的患者,即同时存在 1 种 PPA 亚型的表现和另 1 种 PPA 变异的症状,尸检合并症显示存在多种神经退行性疾病。在纳入研究的 9 名受试者中,8 例发现阿尔茨海默病(AD);然而,仅 1 例 AD 被检测为 PPA 的孤立神经病理学基础。在 8 个脑样本中,检测到不同的合并神经病理学:3 例合并 AD 和路易体痴呆,2 例合并 AD 和 TDP-43 病理学,1 例合并 AD 和复杂的 tau 病,1 例合并 AD 伴 tau 和 TDP-43 沉积。最后,1 例合并 tau 和 TDP-43 病理学,但无 AD 病理学。
我们的观察结果表明,PPA 病例在病因上可能比以前认为的更为复杂,在常规实践中应考虑潜在的神经退行性合并症,尤其是如果 PPA 的临床表现不典型。